Analyst Ratings Archives - Page 44 of 4420

2 minute read

How These 2 Nasdaq-Listed Marijuana Companies Found A Way To Raise $250M Without Tanking Their Stock

June 7, 5:32 PM

This week's Viridian Valuation Tracker investigates the valuation metrics of Canadian cultivation and retail companies with market caps over $100M.

CGC

4 minute read

Analyst Ratings

Decoding 9 Analyst Evaluations For PowerSchool Holdings

By Benzinga Insights

June 7, 5:01 PM

9 analysts have shared their evaluations of PowerSchool Holdings (NYSE:PWSC) during the recent three months, expressing a mix…

PWSC

2 minute read

3M To Focus On Operations, Innovation To Revive Growth, Says New CEO

By Michael Juliano

June 7, 4:22 PM

3M's new CEO Bill Brown aims to refocus on growth and operations. Analyst upgraded shares to Buy with target of $120. Litigation concerns lessen.

MMM

4 minute read

Analyst Ratings

The Analyst Verdict: United Parcel Service In The Eyes Of 17 Experts

By Benzinga Insights

June 7, 4:01 PM

Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on United Parcel…

UPS

4 minute read

Analyst Ratings

Expert Outlook: Carvana Through The Eyes Of 18 Analysts

By Benzinga Insights

June 7, 4:01 PM

Analysts’ ratings for Carvana (NYSE:CVNA) over the last quarter vary from bullish to bearish, as provided by 18…

CVNA

3 minute read

Analyst Ratings

Decoding 10 Analyst Evaluations For Targa Resources

By Benzinga Insights

June 7, 3:01 PM

In the latest quarter, 10 analysts provided ratings for Targa Resources (NYSE:TRGP), showcasing a mix of bullish and…

TRGP

4 minute read

Analyst Ratings

A Glimpse Into The Expert Outlook On CDW Through 8 Analysts

By Benzinga Insights

June 7, 3:01 PM

8 analysts have expressed a variety of opinions on CDW (NASDAQ:CDW) over the past quarter, offering a diverse…

CDW

3 minute read

Analyst Ratings

5 Analysts Have This To Say About Extra Space Storage

By Benzinga Insights

June 7, 3:00 PM

5 analysts have expressed a variety of opinions on Extra Space Storage (NYSE:EXR) over the past quarter, offering…

EXR

4 minute read

Analyst Ratings

Navigating 7 Analyst Ratings For Pagaya Techs

By Benzinga Insights

June 7, 3:00 PM

In the preceding three months, 7 analysts have released ratings for Pagaya Techs (NASDAQ:PGY), presenting a wide array…

PGY

2 minute read

Arcturus’ Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst

By Vandana Singh

June 7, 2:44 PM

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .

ARCT